Vaxart Profit Margin

The latest profit margin for VXRT is 14.51% as of March 2026. That compares with -1.23% in the prior-year period — up 111.8% year over year. That is below the Healthcare sector average of 15.52%. Investors often review this figure alongside Vaxart's historical trend and sector peers before judging valuation or financial health.

Over the past year, VXRT's profit margin moved from -1.23% to 14.51% — a 111.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vaxart's valuation or profitability profile.

Against Healthcare companies, VXRT currently prints 14.51% for profit margin, while the sector average sits near 15.52%. That is roughly 6.5% below the sector mean. Large gaps often invite a closer look at Vaxart's growth, margins, and balance sheet.

Profit Margin shows how effectively Vaxart converts resources into returns. At 14.51%, VXRT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.23% in the prior-year period — up 111.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VXRT's profit margin (14.51%), review year-over-year change from -1.23%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.